Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Egle

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Diagnostics (Basel, Switzerland)|June 26, 2026
Hydrogel-Coated Clips Are Associated with a Higher Risk of Dislocation After Ultrasound-Guided Breast BiopsyMichael Swoboda, Johannes Deeg, Mark Panczel, et al.
Breast Cancer Research and Treatment|February 12, 2011
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)Anne Oberguggenberger, Michael Hubalek, Monika Sztankay, et al.
Cancer Science|February 17, 2010
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumorsRegina Berger, Heidi Fiegl, Georg Goebel, et al.
Journal of Psychosomatic Research|September 25, 2016
Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome studyAnne Oberguggenberger, Monika Sztankay, Raphael Johannes Morscher, et al.
European Radiology Experimental|May 22, 2026
Real-time virtual sonography for prone-position breast MRI: technical feasibility and accuracy in locating 125 breast lesionsLeonhard Gruber, Michael Swoboda, Johannes Deeg, et al.
Breast Care (Basel, Switzerland)|October 9, 2025
New Perspectives in the Management of Triple-Negative Breast CancerRupert Bartsch, Zsuzsanna Bago-Horvath, Daniel Egle, et al.
Frontiers in Immunology|April 3, 2024
Silicone implant surface microtopography modulates inflammation and tissue repair in capsular fibrosisInes Schoberleitner, Klaus Faserl, Christoph H Tripp, et al.
Future Oncology (London, England)|April 9, 2024
Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancerValentina Guarneri, José Luís Passos Coelho, Francois P Duhoux, et al.
Eclinicalmedicine|February 5, 2026
Early detection of medication-related osteonecrosis of the jaw (MRONJ) in patients with metastatic breast cancer using FDG-PET/CT scansMiriam Emmelheinz, Daniel Egle, Samira Abdel Azim, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trialChristian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Diagnostics (Basel, Switzerland)|June 26, 2026
Hydrogel-Coated Clips Are Associated with a Higher Risk of Dislocation After Ultrasound-Guided Breast BiopsyMichael Swoboda, Johannes Deeg, Mark Panczel, et al.
Breast Cancer Research and Treatment|February 12, 2011
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)Anne Oberguggenberger, Michael Hubalek, Monika Sztankay, et al.
Cancer Science|February 17, 2010
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumorsRegina Berger, Heidi Fiegl, Georg Goebel, et al.
Journal of Psychosomatic Research|September 25, 2016
Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome studyAnne Oberguggenberger, Monika Sztankay, Raphael Johannes Morscher, et al.
European Radiology Experimental|May 22, 2026
Real-time virtual sonography for prone-position breast MRI: technical feasibility and accuracy in locating 125 breast lesionsLeonhard Gruber, Michael Swoboda, Johannes Deeg, et al.
Breast Care (Basel, Switzerland)|October 9, 2025
New Perspectives in the Management of Triple-Negative Breast CancerRupert Bartsch, Zsuzsanna Bago-Horvath, Daniel Egle, et al.
Frontiers in Immunology|April 3, 2024
Silicone implant surface microtopography modulates inflammation and tissue repair in capsular fibrosisInes Schoberleitner, Klaus Faserl, Christoph H Tripp, et al.
Future Oncology (London, England)|April 9, 2024
Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancerValentina Guarneri, José Luís Passos Coelho, Francois P Duhoux, et al.
Eclinicalmedicine|February 5, 2026
Early detection of medication-related osteonecrosis of the jaw (MRONJ) in patients with metastatic breast cancer using FDG-PET/CT scansMiriam Emmelheinz, Daniel Egle, Samira Abdel Azim, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trialChristian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
Pageof 9